Breaking News
Sort by:
Top Post
Google Cloud Launches AI-powered Solutions to Safely Accelerate Drug Discovery and Precision Medicine
Google Cloud has announced two new AI-powered life sciences solutions to accelerate drug discovery and […]
Moderna Announces First Participant Dosed in a Phase 1 Trial of Its Nipah Virus mRNA Vaccine, mRNA-1215
Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced […]
Ai-powered Drug Discovery Company Healx Opens New Labs at Chesterford Research Park
Healx, the AI-powered, patient-inspired technology company pioneering the next generation of drug discovery for rare […]
Provepharm Receives FDA Marketing Approval in US for BLUDIGO, Its Indigo Carmine Injection Drug Product
Provepharm, a French company specialized in the development of pharmaceutical applications, today announces that it […]
ABL Partners With KaliVir Immunotherapeutics to Advance Development of Oncolytic Viruses
ABL, a pure play Contract Development and Manufacturing Organization (CDMO) specialized in the development and […]
New Early Breast Cancer Drug to Reduce Risk of Recurrence or Death Now Available in the Philippines
A NEW drug shown to significantly reduce the risk of cancer recurrence or death in […]
Titan Pharmaceuticals Announces FDA Clearance of IND Application for Nalmefene Implant
Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) today announced that the U.S. Food and […]
PreventionGenetics Receives FDA Approval for its Companion Diagnostic Genetic Test as a Class II Medical Device
PreventionGenetics, a subsidiary of Exact Sciences Corp., announced today that it was recently granted marketing […]
Revolution in Care of Leukaemia as New Treatment Drug Approved for Cancer Patients
The charity Leukaemia Care today welcomes the news from the National Institute for Health and Care Excellence […]
GSK Presents Promising New Data for Bepirovirsen, an Investigational Treatment for Chronic Hepatitis B
GSK plc today announced promising interim results from the B-Clear phase IIb trial showing that […]
BioNTech Starts Construction of First mRNA Vaccine Manufacturing Facility in Africa
BioNTech SE (Nasdaq: BNTX, “BioNTech”) has reached the next milestone in the establishment of scalable mRNA […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more